Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.656
-0.022 (-3.26%)
At close: Nov 20, 2024, 4:00 PM
0.650
-0.006 (-0.93%)
Pre-market: Nov 21, 2024, 7:41 AM EST

Ensysce Biosciences Revenue

Ensysce Biosciences had revenue of $3.42M in the quarter ending September 30, 2024, with 685.26% growth. This brings the company's revenue in the last twelve months to $4.42M, up 40.41% year-over-year. In the year 2023, Ensysce Biosciences had annual revenue of $2.23M, down -11.61%.

Revenue (ttm)
$4.42M
Revenue Growth
+40.41%
P/S Ratio
0.96
Revenue / Employee
$631,629
Employees
7
Market Cap
12.83M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.23M-292.86K-11.61%
Dec 31, 20222.52M-1.01M-28.54%
Dec 31, 20213.53M-400.01K-10.18%
Dec 31, 20203.93M2.17M122.86%
Dec 31, 20191.76M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Trinity Biotech 59.13M
Cosmos Health 56.04M
STRATA Skin Sciences 32.68M
Vivos Therapeutics 14.58M
Sol-Gel Technologies 11.71M
Traws Pharma 226.00K
AIM ImmunoTech 190.00K
Revenue Rankings